The ‘dreadful’ decline of a British drug giant – and why RFK could make it worse
Trump’s tariff threats and Kennedy’s anti-vaccine stance makes US a hostile environment for pharma companies ...
Pharmabiz1d
GSK completes acquisition of Boston-based, clinical-stage biopharma company, IDRx, Inc.
GSK completes acquisition of Boston-based, clinical-stage biopharma company, IDRx, Inc.
Contract Pharma1d
GSK Acquires IDRx
GSK plc has completed its previously announced acquisition of IDRx Inc., a Boston-based, clinical-stage biopharmaceutical ...
GSK completes acquisition of IDRx
GSK (GSK) plc announced that it has completed the acquisition of IDRx, Inc., a Boston-based, clinical-stage biopharmaceutical company dedicated ...
PharmiWeb2d
GSK completes acquisition of IDRx, Inc.
GSK plc (LSE/NYSE: GSK) today announced that it has completed the acquisition of IDRx, Inc. (IDRx), a Boston-based, ...
Buy2d
LONDON BRIEFING: FTSE 100 slightly down; Prosus to buy Just Eat
In corporate news, Prosus has agreed to acquire Just Eat Takeaway.com for around EUR4.1 billion. Here is what you need to know at the London market open: FTSE 100: called down 3.1 points at 8,656.27 ...
GSK completes GBP1 billion IDRx purchase; starts GBP2 billion buyback
GSK on Monday also said it has start the GBP2 billion buyback programme that it announced earlier this month, starting with an initial GBP700 million tranche.